Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
VERIONYX, INC. via REGAN MCLANAHAN LLC
2026 · third_quarter · Q3
Federal grants, medical device research and development funding, and federal agency engagement related to health technology innovation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIONYX, INC. via REGAN MCLANAHAN LLC
2026 · second_quarter · Q2
Source: Senate LDA
Federal grants, medical device research and development funding, and federal agency engagement related to health technology innovation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIONYX, INC. via REGAN MCLANAHAN LLC
2026 · first_quarter · Q1
Federal grants, medical device research and development funding, and federal agency engagement related to health technology innovation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIONYX, INC. via REGAN MCLANAHAN LLC
2026 · first_quarter · RR
Federal grants, medical device research and development funding, and federal agency engagement related to health technology innovation.